Furosemide Injection — FDA Drug Shortage

Current — Hospira, Inc., A Pfizer Company

The FDA lists a drug shortage record for Furosemide Injection (injection) from Hospira, Inc., A Pfizer Company with status Current. The shortage was first posted on Apr 7, 2020. Reported reason: Other

Shortage details

Status
Current
Company
Hospira, Inc., A Pfizer Company
Package NDC
0409-6102-25
Dosage Form
Injection
Presentation
Furosemide, Injection, 20 mg/2 mL (10 mg/1 mL) (NDC 0409-6102-25)
Initial Posting
Apr 7, 2020

Reason

Other

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.